Navigation Links
Betsy McCaughey Responds to the Baseless Charges From Rolling Stone Magazine
Date:9/22/2009

SHAME ON ROLLING STONE FOR TAKING TOBACCO MONEY

NEW YORK, Sept. 22 /PRNewswire-USNewswire/ -- The following is a statement by Betsy McCaughey:

The October 1, 2009 issue of Rolling Stone Magazine includes the outrageous and fictional accusation that I worked for a tobacco company in writing my critique of the dangers of the Clinton Plan. I did not. I was a scholar at the Manhattan Institute, and did no fundraising or conferring with corporations. Absolutely none. My article was based on text of the Health Security Act, period. Because of the accuracy and insights in the article, it was awarded a National Magazine Award for the best article in the nation on public policy and the H.L. Mencken Award.

It is shocking that fifteen years later, Rolling Stone still accepts tobacco advertising. See page 93 of the current issue. Shame on hypocritical Rolling Stone Magazine.

All the other baseless accusations made by Rolling Stone Magazine regarding my patient advocacy are old hat. I have rebutted them many times. The article is a tired rerun.

What readers should know is that Rolling Stone would rather try to discredit me (however lamely) rather than address the real issues. One is that Obamacare will mean cruel cuts in healthcare for seniors.


'/>"/>
SOURCE Betsy McCaughey
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Death Panel Inventor & Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris; Healthcare Industry Today Offers Complete Coverage
2. Betsy McCaughey Addresses New York Times: Charges of Falsehoods But No Evidence
3. Betsy McCaughey Rallies to Protect Seniors & Your Healthcare Choices
4. Betsy McCaughey Responds to Poorly Informed Critics
5. Zimmer Holdings Names Betsy Bernard to Board of Directors
6. Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
7. Elizabeth McCaughey Resigns As Director of Cantel Medical
8. Ohio Healthcare Organization Responds to Healthcare Reform
9. UT Southwestern Responds to VA Announcement
10. Burner Balm Responds to Barrage of UK Protests Over New Lip Balm
11. AARP Responds to Health Reform Scare Tactics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: